Applied Biosystems (Foster City, California) recently announced three new value-added services for laboratories that are utilizing Applied Biosystems/MDS SCIEX mass spectrometry (MS) instrument systems as part of an overall workflow solution.
Applied Biosystems (Foster City, California) recently announced three new value-added services for laboratories that are utilizing Applied Biosystems/MDS SCIEX mass spectrometry (MS) instrument systems as part of an overall workflow solution. These new services include: a maintenance program for high-performance liquid chromatography (HPLC) systems manufactured by Agilent Technologies; a software validation consulting service for laboratories operating in regulated environments; and an expanded Web-based solution for remote system monitoring and diagnosis. These specialized services are being offered by Applied Biosystems to support its customers who are increasingly focused on maximizing system productivity, maintaining regulatory compliance and increasing overall return on their technology investments.
The respective services are:
Applied Biosystems is offering these value-added services in response to a growing number of customers who have indicated that direct original equipment manufacturer expertise is preferable in applications in which Applied Biosystems? instrument-based systems, consumables, and software are central to a complete workflow solution.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.